Amicogen Inc. (092040)
Market Closed
7 Aug, 06:30
KRX SM KRX SM Primary ₩
1,024. 00
-19
-1.8217%
₩
100.64B Market Cap
- P/E Ratio
- Div Yield
881,368 Volume
- Eps
₩ 1,043
Previous Close Want to track 092040 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
092040 closed Friday lower at ₩1,024, a decrease of -1.8217% from Thursday's close, completing a monthly decrease of -30.8575% or -₩457. Over the past 12 months, 092040 stock lost -42.6331%.
092040 is not paying dividends to its shareholders.
The last earnings report, released on May 12, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Amicogen Inc. has completed 5 stock splits, with the recent split occurring on Dec 13, 2023.
The company's stock is traded on one exchange.
Amicogen Inc. (092040) FAQ
What is the stock price today?
The current price is ₩1,024.00.
On which exchange is it traded?
Amicogen Inc. is listed on KRX SM.
What is its stock symbol?
The ticker symbol is 092040.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 100.64B.
Has Amicogen Inc. ever had a stock split?
Amicogen Inc. had 5 splits and the recent split was on Dec 13, 2023.
Amicogen Inc. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | - CEO | KRX SM Exchange | KR7092040005 ISIN |
| South Korea Country | 236 Employees | - Last Dividend | 13 Dec 2023 Last Split | - IPO Date |
Overview
Founded in 2000 and headquartered in Jinju-si, South Korea, Amicogen, Inc. stands out as an industrial biotechnology company with an international presence. It is dedicated to innovating within the biotechnology sector by focusing on the development and commercialization of a wide array of specialty enzymes and new bio-ingredients tailored for various industries including pharmaceutical, food, chemical, and energy sectors. Amicogen leverages cutting-edge biotechnological advancements to create products designed for enhancing health and industrial processes. The company’s commitment to research and development ensures the continuous creation of high-quality, efficacious products that cater to global market needs.
Products and Services
- Specialty Enzymes - These include unique formulations like CX, SP, etc., tailored for applications across pharmaceutical, food, chemical, and energy industries. These enzymes are designed to optimize processes, increase efficiency, and support sustainable practices within various sectors.
- Bio-ingredients for Health and Cosmetic Industries
- N-acetylglucosamine: Promotes skin moisturizing and enhances joint health.
- Pinitol/D-chiro-inositol: Natural compounds derived for nutraceutical and diabetic support.
- Collagen Peptide and Collagen Tripeptide: Aimed at improving skin health and providing anti-aging benefits.
- Chitoslim and Chitosan Oligosaccharides: Natural products focused on weight management and cholesterol reduction.
- Lactic Acid Bacteria: Probiotics for supporting digestive health and immune function.
- Fucoxanthin: A marine carotenoid known for its antioxidant properties and potential in aiding weight loss.
- Curezyme: Enzymes designed for specific therapeutic applications.
- Bamboo Salt: A traditional Korean health food product known for its unique therapeutic benefits.
- Consumer Brands
- K-nutra: A healthcare brand that offers a range of products designed for enhancing overall health and well-being.
- KeyClean: A brand dedicated to providing quality disinfectant products for maintaining hygiene and cleanliness.
- Protein Purification Resins - These products are essential for the purification processes in biotechnological and pharmaceutical research, aiding in the isolation of specific proteins for therapeutic or analytical purposes.
Contact Information
Address: 14-10, Wolasan-ro
Phone: 82 5 5759 6161
Website: https://www.amicogen.com
